These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 37296886)

  • 1. PDAC, the Influencer Cancer: Cross-Talk with Tumor Microenvironment and Connected Potential Therapy Strategies.
    Mercanti L; Sindaco M; Mazzone M; Di Marcantonio MC; Piscione M; Muraro R; Mincione G
    Cancers (Basel); 2023 May; 15(11):. PubMed ID: 37296886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic Cancer Microenvironment and Cellular Composition: Current Understandings and Therapeutic Approaches.
    Truong LH; Pauklin S
    Cancers (Basel); 2021 Oct; 13(19):. PubMed ID: 34638513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FAP-targeted CAR-T suppresses MDSCs recruitment to improve the antitumor efficacy of claudin18.2-targeted CAR-T against pancreatic cancer.
    Liu Y; Sun Y; Wang P; Li S; Dong Y; Zhou M; Shi B; Jiang H; Sun R; Li Z
    J Transl Med; 2023 Apr; 21(1):255. PubMed ID: 37046312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiphasic Heterogeneity of Fibroblasts in the Microenvironment of Pancreatic Ductal Adenocarcinoma: Dissection and the Sum of the Dynamics.
    Ijichi H
    Cancers (Basel); 2022 Oct; 14(19):. PubMed ID: 36230803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mast cells in tumor microenvironment promotes the in vivo growth of pancreatic ductal adenocarcinoma.
    Chang DZ; Ma Y; Ji B; Wang H; Deng D; Liu Y; Abbruzzese JL; Liu YJ; Logsdon CD; Hwu P
    Clin Cancer Res; 2011 Nov; 17(22):7015-23. PubMed ID: 21976550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD40L-armed oncolytic herpes simplex virus suppresses pancreatic ductal adenocarcinoma by facilitating the tumor microenvironment favorable to cytotoxic T cell response in the syngeneic mouse model.
    Wang R; Chen J; Wang W; Zhao Z; Wang H; Liu S; Li F; Wan Y; Yin J; Wang R; Li Y; Zhang C; Zhang H; Cao Y
    J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35086948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptosis in the Pancreatic Cancer Tumor Microenvironment-The Double-Edged Sword of Cancer-Associated Fibroblasts.
    Pfeifer E; Burchell JM; Dazzi F; Sarker D; Beatson R
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neural Component of the Tumor Microenvironment in Pancreatic Ductal Adenocarcinoma.
    Gola M; Sejda A; Godlewski J; Cieślak M; Starzyńska A
    Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogenic
    Bansod S; Dodhiawala PB; Lim KH
    Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity and plasticity of cancer-associated fibroblasts in the pancreatic tumor microenvironment.
    Boyd LNC; Andini KD; Peters GJ; Kazemier G; Giovannetti E
    Semin Cancer Biol; 2022 Jul; 82():184-196. PubMed ID: 33737108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KLHDC7B-DT aggravates pancreatic ductal adenocarcinoma development via inducing cross-talk between cancer cells and macrophages.
    Li MX; Wang HY; Yuan CH; Ma ZL; Jiang B; Li L; Zhang L; Xiu DR
    Clin Sci (Lond); 2021 Feb; 135(4):629-649. PubMed ID: 33538300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The reciprocal regulation between host tissue and immune cells in pancreatic ductal adenocarcinoma: new insights and therapeutic implications.
    Liu X; Xu J; Zhang B; Liu J; Liang C; Meng Q; Hua J; Yu X; Shi S
    Mol Cancer; 2019 Dec; 18(1):184. PubMed ID: 31831007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic Tumor Microenvironment.
    Wang K; He H
    Adv Exp Med Biol; 2020; 1296():243-257. PubMed ID: 34185297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new era: tumor microenvironment in chemoresistance of pancreatic cancer.
    Zhao X; Li Z; Gu Z
    J Cancer Sci Clin Ther; 2022; 6(1):61-86. PubMed ID: 35187493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibiting tumor necrosis factor-alpha diminishes desmoplasia and inflammation to overcome chemoresistance in pancreatic ductal adenocarcinoma.
    Zhao X; Fan W; Xu Z; Chen H; He Y; Yang G; Yang G; Hu H; Tang S; Wang P; Zhang Z; Xu P; Yu M
    Oncotarget; 2016 Dec; 7(49):81110-81122. PubMed ID: 27835602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneous tumor microenvironment in pancreatic ductal adenocarcinoma: An emerging role of single-cell analysis.
    Byeon S; du Toit-Thompson T; Gillson J; Gill AJ; Samra JS; Mittal A; Sahni S
    Cancer Med; 2023 Sep; 12(17):18020-18031. PubMed ID: 37537839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current advances and outlooks in immunotherapy for pancreatic ductal adenocarcinoma.
    Fan JQ; Wang MF; Chen HL; Shang D; Das JK; Song J
    Mol Cancer; 2020 Feb; 19(1):32. PubMed ID: 32061257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct Stromal and Immune Features Collectively Contribute to Long-Term Survival in Pancreatic Cancer.
    Sadozai H; Acharjee A; Eppenberger-Castori S; Gloor B; Gruber T; Schenk M; Karamitopoulou E
    Front Immunol; 2021; 12():643529. PubMed ID: 33679807
    [No Abstract]   [Full Text] [Related]  

  • 19. Gene Coexpression Network Characterizing Microenvironmental Heterogeneity and Intercellular Communication in Pancreatic Ductal Adenocarcinoma: Implications of Prognostic Significance and Therapeutic Target.
    Wu C; Liu Y; Wei D; Tao L; Yuan L; Jing T; Wang B
    Front Oncol; 2022; 12():840474. PubMed ID: 35719923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Tango between Cancer-Associated Fibroblasts (CAFs) and Immune Cells in Affecting Immunotherapy Efficacy in Pancreatic Cancer.
    Stouten I; van Montfoort N; Hawinkels LJAC
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.